Y-Intercept (HK)’s Zimmer Biomet ZBH Stock Holding History

Y-Intercept (HK)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,190	Closed	-$469K	–	2241
2026 Q1	$469K	Sell	5,190 -63,137	-92%	-$5.79M	0.01%	1270
2025 Q4	$6.14M	Buy	68,327 +47,374	+226%	+$4.49M	0.14%	165
2025 Q3	$2.06M	Sell	20,953 -18,516	-47%	-$1.83M	0.05%	585
2025 Q2	$3.6M	Buy	+39,469	New	+$3.82M	0.09%	350
2025 Q1	–	Sell	-7,071	Closed	-$747K	–	1672
2024 Q4	$747K	Sell	7,071 -28,766	-80%	-$3.09M	0.05%	550
2024 Q3	$3.87M	Sell	35,837 -4,419	-11%	-$482K	0.24%	74
2024 Q2	$4.37M	Buy	40,256 +31,183	+344%	+$3.68M	0.24%	78
2024 Q1	$1.2M	Buy	9,073 +4,483	+98%	+$560K	0.09%	316
2023 Q4	$559K	Sell	4,590 -51,702	-92%	-$5.77M	0.05%	542
2023 Q3	$6.32M	Buy	+56,292	New	+$7.15M	0.62%	9
2023 Q2	–	Sell	-17,448	Closed	-$2.25M	–	1791
2023 Q1	$2.25M	Buy	+17,448	New	+$2.19M	0.26%	69
2022 Q4	–	Sell	-2,622	Closed	-$274K	–	1409
2022 Q3	$274K	Buy	+2,622	New	+$288K	0.03%	735
2022 Q2	–	Sell	-32,843	Closed	-$4.2M	–	1241
2022 Q1	$4.2M	Buy	+32,843	New	+$3.96M	0.96%	4
2021 Q1	–	Sell	-1,917	Closed	-$283K	–	840
2020 Q4	$283K	Buy	+1,917	New	+$271K	0.12%	328

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Y-Intercept (HK)'s ZBH Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 5,190 shares — an estimated $469K sold.

Y-Intercept (HK) first reported a position in ZBH in Q4 2020 and held it in 14 quarters. The position peaked at $6.32M in Q3 2023. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Y-Intercept (HK) reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 5,190 Zimmer Biomet shares in Q2 2026, an estimated $469K.
Y-Intercept (HK) first reported a position in Zimmer Biomet in Q4 2020 and held it in 14 quarters.
Y-Intercept (HK)'s Zimmer Biomet position peaked at $6.32M in Q3 2023.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.